Fengfen Liu
发表论文 2 篇 · 总被引 5 次 · h-index 1
代表论文
- Disproportionality analysis of post-marketing safety concerns associated with selumetinib in the FDA adverse event reporting system (2025 · Scientific Reports · 被引 5)
- PIH23 A Discrete Event Simulation Model Used for Pharmacoeconomic Evaluation of Omegaven® in the Chinese Setting (2012 · Value in Health)